1. Skip to navigation
  2. Skip to content

Biomedical Polymers and Compounds™

Foster Today!

Foster Expands Nano-Reinforced Polymer Range for Medical Devices

absorption time of bioresorbable materials

Foster Corporation now offers nano-reinforced composites for minimally invasive devices, such as catheters, with reinforcement loadings up to 30% by weight.  Nano-reinforced compounds with high filler loadings provide substantial increase in physical properties of the base resin while maintaining processibility in thin wall components. Foster’s range of nano-reinforced compounds include nylons, TPEs and thermoplastic polyurethanes (TPUs).

Foster Participates in Medical Webinar Series

absorption time of bioresorbable materials

Bill Blasius, Manager of Polymer Science  at Foster Corporation recently participated in a Webinar Series with Hantel Technolgies to discuss the role of a custom compounder in medical device manufacturing. Webinar topics included an introduction to Foster Corporation, a background on Arkema Pebax® Polyamide Elastomers, a briefing of radiopacified polymers for catheter applications, a summary of nanocomposite compounds including properties & processes and finally a formulators perspective on device design possibilies. 

Foster Corporation is hiring!

absorption time of bioresorbable materials

Foster Corporation is actively seeking individuals to join our growing team. Current employment opportuntiies for our Connecticut facility include Project Manager (Pharmacuetical Division), Production Manager/Extrusion Engineer,  Extrusion Operator and Senior Electro-Mechanical Technician. We are also looking for a Senior Electro-Mechanical Technician for the North Las Vegas plant. 

Arkema Lifts Force Majeure for Pebax Materials

absorption time of bioresorbable materials

As of February 5, Arkema has lifted the Force Majeure for Pebax elastomers. The Force Majeure was declared on April 6, 2012, following an explosion at the Evonik manufacuring plant in Marl Germany, which resulted in a sudden shortage of materials. Arkema & Foster are pleased to announce the end of the shortage and return of a normal and healthy supply chain. 

Desired Degradation: Controlling Bioresorbable Polymers for Implantable Medical Devices

absorption time of bioresorbable materials

Lawrence Acquarulo, CEO of Foster Corporation discussd the challenges of working with bioresorbable polymers in the January 2013 issue of Controlled Enviornments. In his analysis Larry accounts for the control processes required for these materials including site inspections of suppliers, analytical testing of the polymers, as well as proper drying and packaging procedures. 

 

Foster Expands Global Engineering Support to Asia Pacific

absorption time of bioresorbable materials

Foster Corporation, a leader in custom polymer formulations for medical device and drug delivery applications, now offers regional technical service and product development support in Asia Pacific. Amar Nilajkar, a ten year veteran of the company, will support medical device and pharmaceutical customers in the region from a newly established office in India.

Bioresorbable Polymers: Patents Growing by 37% a year

absorption time of bioresorbable materials

Foster Corporation, a leader in bioresorbable polymer formulations for implantable medical devices contributed to the article, "Growing Popularity of Bioresorbable Polymers" in the December issue of Medical Plastics News. Tony Listro, Managing Director of Foster Delivery Science discussed compounding, mechanical properties and degredation times, claiming that, "Compositions with higher hydrophilic and amorphous structures and a lower molecular weight resorb faster, yet often sacrifice mechanical strength. Conversely, higher crystallinity and molecular weight improve mechanical properties and decrease resorption rates”. 

Foster Recognized in Deloitte's Technology Fast 500™

absorption time of bioresorbable materials

Foster Corporation was recently ranked in the Deloitte Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America.  Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2007 to 2011. Foster Corporation exerienced revenue growth of 149% during this time period. 

Foster Discounts Material for Small Volume Users

Bonescres
A recent price increase issued by Arkema Inc. for  Pebax® and Rilsan® MED polymers has altered the Foster pricing structure. Despite these escalations, Foster Corporation will be offering a price reduction on small volume purchases beginning on November 15, 2012. Price reductions are intended to stimulate application development programs and will vary among medical grade. 
 

Foster Reports Increased Interest in Implantable Applications by Polymer Suppliers

Bonescres
Foster Corporation, a leader in custom medical polymers, reports increased interest in implantable medical device applications by polymer suppliers.  While risk mitigation remains a primary concern, increased acceptance and application of polymers by device manufacturers for temporary and permanent implants presents opportunities for growth for performance polymers. 

  1. Skip to navigation
  2. Skip to content
  3. Back to top